zavegepant

Trade name: zavzpret

Small moleculeapproved

Approved

Mar 9, 2023

Clinical trial activity

12 trials · 4 clinical orgs · 1 marketing orgs

Phase 1
6
Phase 2
3
Phase 3
4
Phase 4
2

Earliest trial started Oct 27, 2020 (NCT04571060)

Timeline

2020s

  1. Jan 1, 2020

    Earliest Phase 3 Sponsor(trial)

  2. Jan 1, 2021

    Earliest Phase 1 Sponsor(trial)

  3. Jan 1, 2021

    Earliest Phase 2 Sponsor(trial)

  4. Mar 9, 2023

    Pfizer — Earliest FDA Approval

  5. Mar 9, 2023

    Pfizer — Marketing Organization

  6. Mar 9, 2023

    Pfizer — NDA Secondary Org

  7. Mar 9, 2023

    Pfizer — NDA Organization

Indications

Mechanism of action

Approval history

  • approvedMar 9, 2023

Chemistry & pharmacology

Loading structure…

SMILES

Cc1cc(C[C@@H](NC(=O)N2CCC(c3cc4ccccc4[nH]c3=O)CC2)C(=O)N2CCN(C3CCN(C)CC3)CC2)cc2cn[nH]c12
Mol. weight
638.82 g/mol
Lipinski Ro5
1 violation(s)
Rule of 3
No
Chirality
Single Stereoisomer
Inorganic
No
Polymer
No
Delivery
Topical
Availability
Prescription Only

Oral

No

Parenteral

No

Topical

Yes

Sources

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06985342Phase 4Jun 5, 2025Icahn School of Medicine at Mount Sinai, Pfizer
NCT06995729Phase 1May 16, 2025Pfizer
NCT06453356Phase 1Jun 10, 2024Pfizer
NCT06401642Phase 4Mar 22, 2024Mayo Clinic
NCT05989048Phase 3Nov 29, 2023Pfizer
NCT06103734Phase 3Nov 17, 2023Pfizer
NCT05960032Phase 1Oct 23, 2023Pfizer
NCT05948085Phase 1Jul 10, 2023Pfizer
NCT06137703Phase 1Aug 24, 2022Pfizer
NCT04987944Phase 1Oct 18, 2021Biohaven Pharmaceuticals Inc.
NCT04804033Phase 2/Phase 3 (Phase 3)Mar 26, 2021Biohaven Pharmaceuticals Inc.
NCT04571060Phase 3Oct 27, 2020Biohaven Pharmaceuticals Inc.
Showing 12 of 12 trials
Page 1 / 1

Organizations

Research & Development (4)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
PfizerFor profit8732022
Biohaven Pharmaceuticals Inc.For profit3322020
Icahn School of Medicine at Mount SinaiAcademic/Hospital1112025
Mayo ClinicAcademic/Hospital1112024
4 organizations
Page 1 / 1

Marketing (3)

OrganizationOrg typeRelationshipDate
PfizerFor profitMKTGMar 9, 2023
PfizerFor profitNDA2Mar 9, 2023
PfizerFor profitNDAMar 9, 2023